Teva Pharmaceutical Industries Ltd
—- Market cap
- —
- Debt
- —
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: Teva Pharmaceutical Industries Ltd stock price vs FDX: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at FDX's multiple
Needs EPS (TTM), FDX P/E.
Implied fair value · at Teva Pharmaceutical Industries Ltd's multiple
Needs Teva Pharmaceutical Industries Ltd P/E.
Engine logicTeva Pharmaceutical Industries Ltdvalued onFDX’smultiple
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Higher is better
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: Teva Pharmaceutical Industries Ltd Latest annual filing · FDX FY 2026 (ended May 31, 2026). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
TEVA PHARMACEUTICAL INDUSTRIES LTD · implied price per share
Reporting currency could not be verified.
FedEx Corporation · implied price per share
Bear
$134.20
Base
$166.61
Bull
$208.83
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Teva Pharmaceutical Industries Ltd · not enough data.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
—
0.79x
Net debt / EBITDA
Leverage against operating earnings
—
1.73x
Cash and equivalents
Liquid reserves on the balance sheet
—
$13.31B
Total debt
Interest-bearing obligations outstanding
—
$24.97B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
UNITED PARCEL SERVICE INC
Teva Pharmaceutical Industries Ltd vs UPS
C. H. ROBINSON WORLDWIDE, INC.
Teva Pharmaceutical Industries Ltd vs CHRW
HUNT J B TRANSPORT SERVICES INC
Teva Pharmaceutical Industries Ltd vs JBHT
EXPEDITORS INTERNATIONAL OF WASHINGTON INC
Teva Pharmaceutical Industries Ltd vs EXPD
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.